News stories about Owens & Minor (NYSE:OMI) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Owens & Minor earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.2052855805491 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:
- Orosur Mining Inc :OMI-CA: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 (finance.yahoo.com)
- ‘Mini-Crat’ Profile: Owens & Minor Is Cheap With A Safe 4.99% Dividend – Seeking Alpha (seekingalpha.com)
- Gilled, CVS And Two Other Stocks Down But Not Out (finance.yahoo.com)
- Bed Pans To Bariatric Chairs: Owens & Minor Has It All – Seeking Alpha (seekingalpha.com)
Shares of Owens & Minor (OMI) opened at $21.46 on Friday. Owens & Minor has a one year low of $17.75 and a one year high of $37.00. The stock has a market cap of $1,297.88, a price-to-earnings ratio of 16.77, a P/E/G ratio of 1.80 and a beta of 0.88. The company has a quick ratio of 0.95, a current ratio of 1.77 and a debt-to-equity ratio of 0.91.
The business also recently declared a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were paid a $0.2575 dividend. The ex-dividend date was Thursday, December 14th. This represents a $1.03 dividend on an annualized basis and a yield of 4.80%. Owens & Minor’s dividend payout ratio is currently 80.47%.
A number of equities research analysts have recently commented on the stock. Zacks Investment Research raised shares of Owens & Minor from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. ValuEngine cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. JPMorgan Chase & Co. reissued an “underweight” rating and issued a $22.00 price target on shares of Owens & Minor in a research note on Tuesday, December 19th. Credit Suisse Group reissued an “underperform” rating and issued a $17.00 price target (down previously from $31.00) on shares of Owens & Minor in a research note on Monday, November 20th. Finally, Leerink Swann reissued a “market perform” rating and issued a $23.00 price target (down previously from $34.00) on shares of Owens & Minor in a research note on Thursday, November 2nd. Four equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company’s stock. Owens & Minor has a consensus rating of “Hold” and an average target price of $26.50.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3148592/owens-minor-omi-receiving-somewhat-favorable-news-coverage-report-finds.html.
Owens & Minor Company Profile
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.